Cargando…
A Case of Phage Therapy against Pandrug-Resistant Achromobacter xylosoxidans in a 12-Year-Old Lung-Transplanted Cystic Fibrosis Patient
Bacteriophages are a promising therapeutic strategy among cystic fibrosis and lung-transplanted patients, considering the high frequency of colonization/infection caused by pandrug-resistant bacteria. However, little clinical data are available regarding the use of phages for infections with Achromo...
Autores principales: | Lebeaux, David, Merabishvili, Maia, Caudron, Eric, Lannoy, Damien, Van Simaey, Leen, Duyvejonck, Hans, Guillemain, Romain, Thumerelle, Caroline, Podglajen, Isabelle, Compain, Fabrice, Kassis, Najiby, Mainardi, Jean-Luc, Wittmann, Johannes, Rohde, Christine, Pirnay, Jean-Paul, Dufour, Nicolas, Vermeulen, Stefan, Gansemans, Yannick, Van Nieuwerburgh, Filip, Vaneechoutte, Mario |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7824836/ https://www.ncbi.nlm.nih.gov/pubmed/33466377 http://dx.doi.org/10.3390/v13010060 |
Ejemplares similares
-
Epidemic Achromobacter xylosoxidans strain among Belgian cystic fibrosis patients and review of literature
por: Cools, Piet, et al.
Publicado: (2016) -
Osteomyelitis caused by Achromobacter xylosoxidans
por: Shinha, Takashi, et al.
Publicado: (2015) -
Pacemaker Lead Endocarditis Caused by Achromobacter xylosoxidans
por: Ahn, Youngkeun, et al.
Publicado: (2004) -
Ecthyma gangrenosum caused by Achromobacter xylosoxidans bacteremia
por: Alkan, Sevil
Publicado: (2023) -
Duplex real-time PCR assay for the simultaneous detection of Achromobacter xylosoxidans and Achromobacter spp.
por: Price, Erin P., et al.
Publicado: (2020)